Tudor Investment Corporation »

Tarsus Pharmaceuticals shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2024-12-31 $769k 14k 55.37
2024-03-31 $680k 19k 36.35
2023-09-30 $889k 50k 17.77

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Tarsus Pharmaceuticals

BlackRock
Rtw Investments
Deep Track Capital
Paradigm Biocapital Advisors
Jennison Associates
Tang Capital Management
Vanguard Group
Morgan Stanley
Henderson Group
Assenagon Asset Management
Frazier Life Sciences Management
Driehaus Capital Management
Lord, Abbett & Co
Geode Capital Management
Invesco

View all funds holding Tarsus Pharmaceuticals